Ebru Alp
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
Papers in
-
- Protease and Inhibitor Mechanisms 3
- Cancer-related molecular mechanisms research 3
-
- Sirtuins and Resveratrol in Medicine 4
- Co-authors
- Sevda Menevşe (18 shared papers)Ece Konaç (12 shared papers)Hacer İlke Önen (13 shared papers)Akın Yılmaz (14 shared papers)Aydan Bırı (5 shared papers)Abdullah Ekmekçi (4 shared papers)Zübeyir Elmazoğlu (2 shared papers)Atiye Seda Yar Sağlam (6 shared papers)
- Journals
- DNA and Cell Biology (3 papers)Human & Experimental Toxicology (3 papers)Molecular Biology Reports (2 papers)Gene (1 paper)Ophthalmic Genetics (1 paper)
- Partner nations
- Türkiye
In The Last Decade
Ebru Alp
35 papers receiving 657 citations
Peers
Comparison fields: 5 of 77
- Geriatrics and Gerontology 60
- Cancer Research 159
- Toxicology 23
- Reproductive Medicine 45
- Biochemistry 30
Countries citing papers authored by Ebru Alp
This map shows the geographic impact of Ebru Alp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Alp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Alp more than expected).
Fields of papers citing papers by Ebru Alp
This network shows the impact of papers produced by Ebru Alp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Alp. The network helps show where Ebru Alp may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Alp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 66 | |
| 2 | 2015 | 65 | |
| 3 | 2007 | 55 | |
| 4 | 2011 | 48 | |
| 5 | 2009 | 36 | |
| 6 | 2017 | 35 | |
| 7 | 2011 | 35 | |
| 8 | 2009 | 32 | |
| 9 | 2009 | 31 | |
| 10 | 2007 | 27 | |
| 11 | 2009 | 26 | |
| 12 | 2010 | 26 | |
| 13 | 2012 | 23 | |
| 14 | 2014 | 20 | |
| 15 | 2016 | 16 | |
| 16 | 2017 | 15 | |
| 17 | 2021 | 13 | |
| 18 | 2014 | 12 | |
| 19 | 2016 | 12 | |
| 20 | 2016 | 12 |
About Ebru Alp
Ebru Alp is a scholar working on Cancer Research, Geriatrics and Gerontology, Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology, having authored 37 papers that have together received 669 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Protease and Inhibitor Mechanisms (3 papers), Cancer-related molecular mechanisms research (3 papers), Signaling Pathways in Disease (2 papers), Cancer Mechanisms and Therapy (2 papers), Reproductive System and Pregnancy (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Geriatrics and Gerontology (60 citations), Cancer Research (159 citations), Toxicology (23 citations), Reproductive Medicine (45 citations) and Biochemistry (30 citations). Ebru Alp has collaborated with scholars based in Türkiye. Frequent co-authors include Sevda Menevşe, Ece Konaç, Hacer İlke Önen, Akın Yılmaz, Aydan Bırı, Abdullah Ekmekçi, Zübeyir Elmazoğlu, Atiye Seda Yar Sağlam, Atiye Çengel and Murat Tulmaç. Their work appears in journals such as DNA and Cell Biology, Human & Experimental Toxicology, Molecular Biology Reports, Gene and Ophthalmic Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.